Data gathered: January 30
Alternative Data for Quest Diagnostics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1,595 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 14,781,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 82 | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 200 | Sign up | Sign up | Sign up |
| Facebook Followers | 36,447 | Sign up | Sign up | Sign up |
| Instagram Followers | 10,977 | Sign up | Sign up | Sign up |
| Reddit Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,682 | Sign up | Sign up | Sign up |
| Twitter Followers | 12,874 | Sign up | Sign up | Sign up |
| Twitter Mentions | 38 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 7,420 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | 30 | Sign up | Sign up | Sign up |
| Lobbying Cost | $137,000 | Sign up | Sign up | Sign up |
| Business Outlook | 49 | Sign up | Sign up | Sign up |
| Linkedin Employees | 28,678 | Sign up | Sign up | Sign up |
About Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses.
| Price | $164.70 |
| Target Price | Sign up |
| Volume | 691,200 |
| Market Cap | $17.5B |
| Year Range | $134.57 - $164.7 |
| Dividend Yield | 1.88% |
| PE Ratio | 21.15 |
| Analyst Rating | 86% buy |
| Earnings Date | January 30 '25 |
| Industry | Health Care Services |
In the news
 |
Fifth Third Bancorp Purchases 1,009 Shares of Quest Diagnostics Incorporated (NYSE:DGX)January 30 - ETF Daily News |
|
Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by Exchange Traded Concepts LLCJanuary 29 - ETF Daily News |
|
Mutual Advisors LLC Takes Position in Quest Diagnostics Incorporated (NYSE:DGX)January 29 - ETF Daily News |
 |
Quest Diagnostics: Good Growth Prospects, But Little To No Upside Left At Current ValuationJanuary 27 - SeekingAlpha |
|
Dakota Wealth Management Purchases New Position in Quest Diagnostics Incorporated (NYSE:DGX)January 27 - ETF Daily News |
Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University HospitalsJanuary 26 - Finnhub |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 2.44B | 1.68B | 762M | 226M | 362M | 2.300 |
| Q2 '24 | 2.35B | 1.59B | 760M | 229M | 379M | 2.350 |
| Q1 '24 | 2.32B | 1.6B | 728M | 194M | 338M | 2.040 |
| Q4 '23 | 2.25B | 1.55B | 696M | 192M | 307M | 2.150 |
| Q3 '23 | 2.26B | 1.54B | 714M | 225M | 361M | 2.220 |
Insider Transactions View All
| PREVOZNIK MICHAEL E filed to sell 70,615 shares at $162.3. December 2 '24 |
| PREVOZNIK MICHAEL E filed to sell 38,478 shares at $163.1. December 2 '24 |
| Doherty Catherine T. filed to sell 96,712 shares at $162.1. December 2 '24 |
| Doherty Catherine T. filed to sell 68,412 shares at $163.1. December 2 '24 |
| DEPPE MICHAEL J filed to sell 51,596 shares at $152.7. November 7 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
| Earl Blumenauer Democrat |
May 4, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Mar 6, 24 | Sell | $1K - $15K |
Read more about Quest Diagnostics (DGX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Quest Diagnostics?
The Market Cap of Quest Diagnostics is $17.5B.
What is Quest Diagnostics' PE Ratio?
As of today, Quest Diagnostics' PE (Price to Earnings) ratio is 21.15.
When does Quest Diagnostics report earnings?
Quest Diagnostics will report its next earnings on January 30 '25.
What is the current stock price of Quest Diagnostics?
Currently, the price of one share of Quest Diagnostics stock is $164.70.
How can I analyze the DGX stock price chart for investment decisions?
The DGX stock price chart above provides a comprehensive visual representation of Quest Diagnostics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Quest Diagnostics shares. Our platform offers an up-to-date DGX stock price chart, along with technical data analysis and alternative data insights.
Does DGX offer dividends to its shareholders?
Yes, Quest Diagnostics (DGX) offers dividends to its shareholders, with a dividend yield of 1.88%. This dividend yield represents Quest Diagnostics' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Quest Diagnostics in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Quest Diagnostics?
Some of the similar stocks of Quest Diagnostics are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.